Publications 2026

Suul SG, Kvam AK, Hestdalen ML, Randen U, Midtvedt Ø, Tjønnfjord GE (2026)
Cryoglobulinemia Type II: Sustained Remission After B-Cell-Directed Therapy
Am J Case Rep, 27, e950857
DOI 10.12659/AJCR.950857, PubMed 41792990

Tjønnfjord GE, Osnes LTN, Spetalen S, Haave U, Popperud TH, Maniaol AH, Østlie I, Bajelan L, Hamnvik LHD, Marvyin K, Miskovic D, Tjønnfjord EB, Winje K, Moksnes M, Tvedt THA, Kvam AK, Malecka A (2026)
Anti-MAG Polyneuropathy: Characterization of the Monoclonal Gammopathy and Clonal B-Cell Population
J Immunol Res, 2026 (1), e1959235
DOI 10.1155/jimr/1959235, PubMed 42396941

Publications 2025

Podgorica M, Drivet E, Vestbøstad J, Kvam AK, Wik HS, Munthe L, Schjerven H (2025)
Azaindole 1, a selective Rock1/2 kinase inhibitor, induces G2/M arrest and cell death in B-cell acute lymphoblastic leukemia (B-ALL)
Leuk Lymphoma, 66 (12), 2311-2315
DOI 10.1080/10428194.2025.2536125, PubMed 40728071

Publications 2024

Podgorica M, Drivet E, Viken JK, Richman A, Vestbøstad J, Szodoray P, Kvam AK, Wik HS, Tjønnfjord GE, Munthe LA, Frietze S, Schjerven H (2024)
Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
Eur J Haematol, 112 (5), 731-742
DOI 10.1111/ejh.14164, PubMed 38192186

Publications 2021

Kvam AK, Torp HA, Iversen PO (2021)
Life-Threatening Acute Chest Syndrome in a Patient With Sickle Cell Disease After Switching From Hydroxyurea Therapy to Partial Exchange Transfusions: A Case Report
Cureus, 13 (12), e20236
DOI 10.7759/cureus.20236, PubMed 35004051

Tjonnfjord GE, Schjesvold FH, Gulbrandsen N, Kvam AK (2021)
Monoclonal gammopathy of clinical importance
Tidsskr. Nor. Laegeforen., 141 (13), 1276-1280

Tjønnfjord GE, Schjesvold FH, Gulbrandsen N, Kvam AK (2021)
[Monoclonal gammopathy of clinical importance]
Tidsskr Nor Laegeforen, 141 (2021-13)
DOI 10.4045/tidsskr.20.0981, PubMed 34596996

Publications 2020

Hagestande S, Kvam AK, Lothe IMB, Gjelberg HK, Bruserud O, Tvedt THA (2020)
Aplastic anaemia
Tidsskr. Nor. Laegeforen., 140 (18), 1897-1900

Hagestande S, Kvam AK, Lothe IMB, Gjelberg HK, Bruserud Ø, Tvedt THA (2020)
[Aplastic anaemia]
Tidsskr Nor Laegeforen, 140 (18)
DOI 10.4045/tidsskr.20.0139, PubMed 33322881

Publications 2016

Barratt-Due A, Fløisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tjønnfjord GE, Mollnes TE (2016)
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
Rheumatology (Oxford), 55 (7), 1337-9
DOI 10.1093/rheumatology/kew040, PubMed 27105662

Publications 2015

Kvam AK, Waage A (2015)
Health-related quality of life in patients with multiple myeloma--does it matter?
Haematologica, 100 (6), 704-5
DOI 10.3324/haematol.2015.127860, PubMed 26034111

Publications 2013

Enden T, Wik HS, Kvam AK, Haig Y, Kløw NE, Sandset PM (2013)
Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study
BMJ Open, 3 (8), e002984
DOI 10.1136/bmjopen-2013-002984, PubMed 23988361

Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukås E, Carlson K, Kvam AK, Nahi H, Lindås R, Andersen NF, Turesson I, Waage A, Westin J et al. (2013)
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Blood, 121 (23), 4647-54
DOI 10.1182/blood-2012-11-464503, PubMed 23616624

Publications 2011

Kvam AK, Fayers PM, Wisloff F (2011)
Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma
Eur J Haematol, 87 (4), 330-7
DOI 10.1111/j.1600-0609.2011.01665.x, PubMed 21668504

Publications 2010

Kvam AK, Wisløff F, Fayers PM (2010)
Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma
Health Qual Life Outcomes, 8, 79
DOI 10.1186/1477-7525-8-79, PubMed 20678240

Publications 2009

Kvam AK, Fayers P, Hjermstad M, Gulbrandsen N, Wisloff F (2009)
Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations
Eur J Haematol, 83 (4), 279-89
DOI 10.1111/j.1600-0609.2009.01303.x, PubMed 19558508

Kvam AK, Fayers P, Wisloff F (2009)
What changes in health-related quality of life matter to multiple myeloma patients? A prospective study
Eur J Haematol, 84 (4), 345-53
DOI 10.1111/j.1600-0609.2009.01404.x, PubMed 20041946

Publications 2006

Wisløff F, Kvam AK, Hjorth M, Lenhoff S (2006)
Serum calcium is an independent predictor of quality of life in multiple myeloma
Eur J Haematol, 78 (1), 29-34
DOI 10.1111/j.0902-4441.2006.t01-1-EJH2887.x, PubMed 17038019